Ascierto, P. A., Minor, D., Ribas, A., Lebbe, C., O’Hagan, A., Arya, N., … Trefzer, U. (2013). Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic Melanoma. Journal of Clinical Oncology, 31(26), 3205–3211. doi:10.1200/jco.2013.49.8691
